NCT06119152

Brief Summary

A community-academic partnership composed of a State University of New York (SUNY) Downstate Health Sciences University inter-disciplinary team of scientists (representing public health, medical informatics, vascular neurology/stroke center) and the Digital Equity Community Advisory Board (DECA) will guide our research. This is an NIH R21 pilot study. Our Specific Aims are designed to inform the sample design and research priorities for a larger NIH R01 experimental study and to serve as a platform for similar studies with other health conditions. We propose a mixed-methods study design with the following aims:

  1. 1.Assess and build setting, community, and user fit of DESA, leveraging qualitative methods and simulation telehealth encounters between the patient and neurologist.
  2. 2.Conduct a 9-month pilot randomized control trial (RCT) of DESA in a Central Brooklyn stroke population to examine the feasibility and preliminary efficacy. We will randomize 50 adults to DESA and 30 to usual care. The primary outcome will be BP control. Secondary outcomes include the number of BP measurements and medication compliance. Our primary hypothesis is that patients randomized to the DESA will significantly reduce systolic blood pressure at 9 months.
  3. 3.Examine barriers and facilitators to the adoption and integration of DESA into routine stroke care utilizing key informant interviews and user satisfaction surveys with neurologists and intervention participants.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started Oct 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 11, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

October 17, 2023

Completed
21 days until next milestone

First Posted

Study publicly available on registry

November 7, 2023

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 17, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2025

Completed
Last Updated

November 7, 2023

Status Verified

November 1, 2023

Enrollment Period

1 year

First QC Date

July 11, 2023

Last Update Submit

November 2, 2023

Conditions

Keywords

TelehealthDigital HealthRemote Device MonitoringHealth DisparitiesAfro-Caribbean

Outcome Measures

Primary Outcomes (1)

  • Blood Pressure Change

    Blood Pressure (Systolic and Diastolic) will be recorded by telehealth device daily

    9 months

Secondary Outcomes (2)

  • Number of Blood Pressure readings/week

    9 months

  • Medication Adherence

    9 months

Study Arms (2)

Control

NO INTERVENTION

Usual Care

Intervention

EXPERIMENTAL

The DESA Intervention will use a telehealth device to help the patient take blood pressure daily, and monitor blood pressure management.

Behavioral: DESA

Interventions

DESABEHAVIORAL

Intervention group is monitored via remote bp monitoring and telehealth device.

Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • African American or Afro-Caribbean
  • years or over
  • Experienced a stroke in the last 6 years
  • A score between 2 and 4 on the Modified Rankin Scale2
  • Has a formal or informal caregiver (e.g., relative, health aide or other) to assist them in activities of daily living
  • Has a primary care physician at University Hospital of Brooklyn (UHB)

You may not qualify if:

  • Mental illness (severe depression)
  • dementia
  • Non-English speakers
  • aphasia
  • severe dysarthria (slurred speech/impediment)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital at Downstate

Brooklyn, New York, 11203, United States

RECRUITING

MeSH Terms

Conditions

StrokeHypertension

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • David R Kaufman, PhD, FACMI

    SUNY Downstate Health Sciences University

    PRINCIPAL INVESTIGATOR
  • Aimee Afable, PhD, MPH

    SUNY Downstate Health Sciences University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Aimee Afable, PhD, Mph

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 11, 2023

First Posted

November 7, 2023

Study Start

October 17, 2023

Primary Completion

October 17, 2024

Study Completion

February 28, 2025

Last Updated

November 7, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations